Setting A New Standard
For Inclusive Research
Smiling photo of Mitzi Joi Williams, M.D., Founder & CEO, Joi Life Wellness MS Center, Lead Investigator, CHIMES Study

As science and technology move forward, far too many communities are left behind. Despite making up almost 20% of the population with multiple sclerosis (MS), Black and Hispanic/Latinx people living with the disease have historically been underrepresented in clinical studies, even though they may experience more severe disease and greater disability.

That's why we conducted our Phase IV CHIMES clinical study. This study set a new standard for inclusive clinical research, incorporating proactive measures like flexible scheduling, appropriate compensation for expenses related to participation, and ride-sharing options to overcome barriers to recruitment and retention among Black and Hispanic/Latinx people with MS.

Watch Mitzi Joi Williams, M.D., discuss Multiple Sclerosis and Race: Confronting Inequities on the Sherri Shepherd show.

The CHIMES study is a critical step in breaking the cycle of health inequity. The results provide evidence of the benefit of treatment in Black and Hispanic/Latinx people with MS.
Our people data
As part of our commitment to Diversity & Inclusion, we are sharing enterprise-wide data related to our gender representation, race/ethnicity representation, and pay practices.
Answer The Call
We are looking for transformative visionaries like you to improve lives, patient care, and health equity. Your career is at Genentech.
Join Us
Genentech Logo
Genentech Logo
© 2023 Genentech USA, Inc. All rights reserved. This site is intended for US residents only.